Dr. David Nathaniel Blitzer, MD

Dr. Blitzer practices at Ventura ASC LLC in Ventura, California.

Dr. Blitzer's NPI, 1275996142, was assigned on March 30, 2016. Dr. Blitzer graduated from Rutgers Robert Wood Johnson Medical School in 2016. Dr. Blitzer holds California license A186757.

Dr. Blitzer's primary practice is Ventura ASC LLC, at 100 N Brent St, Ventura, CA 93003 in Ventura County. The practice phone is (805) 643-3330.

Dr. Blitzer's primary practice is Ventura ASC LLC in Ventura, California. Dr. Blitzer is also affiliated with Community Memorial Hospital - Ventura. The medical group on file is Pacific Cardiovascular & Vein Institute. Dmand AI also links Dr. Blitzer to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blitzer practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Blitzer's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Blitzer is board certified in vascular surgery by the American Board of Surgery. Dr. Blitzer is licensed in California.

Dmand AI lists chronic skin ulcer, peripheral vascular disease and varicose veins among the conditions Dr. Blitzer treats.

CMS data shows 2,595 Medicare services from Dr. Blitzer across 29 procedure codes in 2024, for 710 Medicare patients. Medicare paid $184,670 for them.

CMS counts 710 Medicare patients who saw Dr. Blitzer in 2024. The largest group is 75 to 84, with 268 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blitzer's median patient age at 71, with 51% women.

In 2024, Dr. Blitzer wrote 125 Medicare Part D claims for 64 patients. 92% of them were for generic drugs. CMS names the drug for 47 of them, across 2 drugs with 11 or more claims each, at $432 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Blitzer for performance year 2024, reported as part of a group. Dr. Blitzer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 33 procedures of leg revascularization (restoring blood flow) by Dr. Blitzer, more than 90% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Blitzer, published from 2019 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Lower Extremity, Amputation, Surgical and Carotid Artery Injuries. Dr. Blitzer has published most often in Ann Vasc Surg. Dr. Blitzer's most frequent co-authors are Khanjan H. Nagarsheth, MD, Shahab A. Toursavadkohi, MD and Nicholas Rolle, MD.

CMS Open Payments shows 104 general payments to Dr. Blitzer from 19 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 50% of the total. AngioDynamics, Inc. paid the most, $3,750.

Dr. Blitzer graduated from Rutgers Robert Wood Johnson Medical School in 2016.

Dr. Blitzer is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.